Udskriv Udskriv
Switch language
Region Hovedstadens Psykiatri - en del af Københavns Universitetshospital

Primary prevention of depression: An umbrella review of controlled interventions

Publikation: Bidrag til tidsskriftReviewForskningpeer review


  1. Alzheimer's disease related biomarkers in bipolar disorder - A longitudinal one-year case-control study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Reduced prefrontal cortex response to own vs. unknown emotional infant faces in mothers with bipolar disorder

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Incomplete systematic review and meta-analysis on statin use and depression risk - A commentary

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  • Gonzalo Salazar de Pablo
  • Marco Solmi
  • Julio Vaquerizo-Serrano
  • Joaquim Radua
  • Anastassia Passina
  • Pierluca Morsillo
  • Christoph U Correll
  • Stefan Borgwardt
  • Silvana Galderisi
  • Andreas Bechdolf
  • Andrea Pfennig
  • Michael Bauer
  • Lars Vedel Kessing
  • Therese van Amelsvoort
  • Dorien H Nieman
  • Katharina Domschke
  • Marie-Odile Krebs
  • Michael Sand
  • Eduard Vieta
  • Philip McGuire
  • Celso Arango
  • Jae Il Shin
  • Paolo Fusar-Poli
Vis graf over relationer

BACKGROUND: Primary prevention has the potential to modify the course of depression, but the consistency and magnitude of this effect are currently undetermined.

METHODS: PRISMA and RIGHT compliant (PROSPERO:CRD42020179659) systematic meta-review, PubMed/Web of Science, up to June 2020. Meta-analyses of controlled interventions for the primary prevention of depressive symptoms [effect measures: standardized mean difference (SMD)] or depressive disorders [effect measure: relative risk (RR)] were carried out. Results were stratified by: (i) age range; (ii) target population (general and/or at-risk); (iii) intervention type. Quality (assessed with AMSTAR/AMSTAR-PLUS content) and credibility (graded as high/moderate/low) were assessed. USPSTF grading system was used for recommendations.

RESULTS: Forty-six meta-analyses (k=928 individual studies, n=286,429 individuals, mean age=22.4 years, 81.1% female) were included. Effect sizes were: SMD=0.08-0.53; for depressive symptoms; RR=0.90-0.28 for depressive disorders. Sensitivity analyses including only RCTs did not impact the findings. AMSTAR median=9 (IQR=8-9); AMSTAR-PLUS content median=4.25 (IQR=4-5). Credibility of the evidence was insufficient/low in 43 (93.5%) meta-analyses, moderate in two (4.3%), and high in one (2.2%): reduction of depressive symptoms using psychosocial interventions for young adults only, and a combination of psychological and educational interventions in primary care had moderate credibility; preventive administration of selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in individuals with a stroke had high credibility.

LIMITATIONS: Intervention heterogeneity and lack of long-term efficacy evaluation.

CONCLUSIONS: Primary preventive interventions for depression might be effective. Among them, clinicians may offer SSRIs post-stroke to prevent depressive disorders, and psychosocial interventions for children/adolescents/young adults with risk factors or during the prenatal/perinatal period.

TidsskriftJournal of Affective Disorders
Sider (fra-til)957-970
Antal sider14
StatusUdgivet - 1 nov. 2021

ID: 67030726